KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) FCF Payout Ratio (2020 - 2025)

Historic FCF Payout Ratio for Evolent Health (EVH) over the last 6 years, with Q3 2025 value amounting to 0.28.

  • Evolent Health's FCF Payout Ratio fell 3208.88% to 0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23, marking a year-over-year decrease of 22439.33%. This contributed to the annual value of 3.28 for FY2024, which is 208536.52% down from last year.
  • As of Q3 2025, Evolent Health's FCF Payout Ratio stood at 0.28, which was down 3208.88% from 0.12 recorded in Q2 2025.
  • Evolent Health's 5-year FCF Payout Ratio high stood at 3.11 for Q2 2022, and its period low was 11.59 during Q1 2024.
  • For the 5-year period, Evolent Health's FCF Payout Ratio averaged around 0.7, with its median value being 0.03 (2022).
  • As far as peak fluctuations go, Evolent Health's FCF Payout Ratio soared by 724007.56% in 2022, and later crashed by 530749.22% in 2024.
  • Evolent Health's FCF Payout Ratio (Quarter) stood at 0.04 in 2021, then surged by 7240.08% to 3.11 in 2022, then tumbled by 98.01% to 0.06 in 2023, then plummeted by 339.58% to 0.15 in 2024, then surged by 289.74% to 0.28 in 2025.
  • Its FCF Payout Ratio was 0.28 in Q3 2025, compared to 0.12 in Q2 2025 and 1.14 in Q1 2025.